a developer of innovative human medicines
Industry PharmaceuticalsGeneric
This is a Bullish indicator signaling IRWD's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 45 similar cases where IRWD's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:
The Moving Average Convergence Divergence (MACD) for IRWD turned positive on October 28, 2026. Looking at past instances where IRWD's MACD turned positive, the stock continued to rise in 31 of 43 cases over the following month. The odds of a continued upward trend are 72%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on IRWD as a result. In 68 of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
IRWD moved above its 50-day moving average on November 05, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IRWD crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
The 50-day moving average for IRWD moved above the 200-day moving average on November 12, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +0.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRWD advanced for three days, in 182 of 264 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRWD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
IRWD broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IRWD entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-4.482) is normal, around the industry mean (6.379). P/E Ratio (5.488) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (1.780) is also within normal values, averaging (183.387).
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. IRWD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IRWD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.